This Week in Virology

TWiV 661: SWAG with Ralph Baric

Ralph Baric returns to TWiV to provide an update on the COVID-19 resurgence in the US, monoclonal antibodies, antiviral drugs, vaccines, immunity and reinfection, reopening schools, and what will happen this fall. Click arrow to playDownload TWiV 661 (70 MB .mp3, 116 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv

TWiV 660: In case of emergency finish the trial

Daniel Griffin provides a clinical report on COVID-19, then we discuss decline of virus-specific bone marrow B cells within a year after influenza vaccination, the push to release SARS-CoV-2 vaccines before completion of phase 3 trials, and absence of evidence for infectious virus in aerosols. Click arrow to playDownload TWiV 660 (95 MB .mp3, 159 min)Subscribe …

TWiV 660: In case of emergency finish the trial Read More »

TWiV 659: Sloppy coronavirus immunity with Christian Drosten

Christian Drosten returns to TWiV to provide an update on the COVID-19 situation in Germany, and general thoughts on testing, immunity, vaccines, therapeutics, epidemiology, reopening schools, and what will happen this fall. Click arrow to playDownload TWiV 659 (72 MB .mp3, 120 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv

TWiV 658: Everyone needs a H.E.A.R.T.

Daniel Griffin provides a clinical report on COVID-19, then we discuss CDC softening testing guidelines, Moderna vaccine phase I results in older people, Abbott’s $5 rapid antigen test, and reinfection with a distinct SARS-CoV-2 isolate, followed by listener email. Click arrow to playDownload TWiV 658 (85 MB .mp3, 141 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes …

TWiV 658: Everyone needs a H.E.A.R.T. Read More »

TWiV 655: Minority health with Robert Fullilove

Sociomedical scientist Robert Fullilove joins TWiV to discuss disparities in minority health; FDA announces an EUA on Yale’s SalivaDirect, protection of the upper and respiratory tract of mice after intranasal inoculation with an adenovirus-vectored SARS-CoV-2 spike gene, and listener questions. Click arrow to playDownload TWiV 655 (88 MB .mp3, 147 min)Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show …

TWiV 655: Minority health with Robert Fullilove Read More »

Scroll to Top